Affiner les résultats

Platinum reward for theft, or the percutaneous treatment of coronary steal due to a giant coronary artery fistula

Arroyo, Dieggo ; Cook, Stéphane

In: Kardiovaskuläre Medizin, 2010, vol. 13, no. 2, p. 68-69

Comparison of everolimus-eluting and biolimus-eluting coronary stents with everolimus-eluting bioresorbable scaffold: study protocol of the randomized controlled EVERBIO II trial

Arroyo, Diego ; Togni, Mario ; Puricel, Serban ; Gerard, Baeriswyl ; Sonja, Lehmann ; Corpataux, Noé ; Villeneuve, Hélène ; Boute, Estelle ; Stauffer, Jean-Christophe ; Goy, Jean-Jacques ; Cook, Stéphane

In: Trials, 2014, vol. 15, no. 1, p. 9

Background: Second-generation everolimus-eluting stents (EES) and third generation biolimus-eluting stents (BES) have been shown to be superior to first-generation paclitaxel-eluting stents (PES) and second-generation sirolimus-eluting stents (SES). However, neointimal proliferation and very late stent thrombosis is still an unresolved issue of drug-eluting stent (DES) implantation overall. The...

Percutaneous ventricular assist devices: new deus ex machina?

Arroyo, Diego ; Cook, Stéphane

In: Minimally Invasive Surgery, 2011, p. -

The development of ventricular assist devices has broadened the means with which one can treat acute heart failure. Percutaneous ventricular assist devices (pVAD) have risen from recent technological advances. They are smaller, easier, and faster to implant, all important qualities in the setting of acute heart failure. The present paper briefly describes the functioning and assets of the most...

Two-year clinical outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents in diabetic patients

Billinger, Michael ; Beutler, Jonas ; Taghetchian, Keywan R. ; Remondino, Andrea ; Wenaweser, Peter ; Cook, Stéphane ; Togni, Mario ; Seiler, Christian ; Stettler, Christoph ; Eberli, Franz R. ; Lüscher, Thomas F. ; Wandel, Simon ; Jüni, Peter ; Meier, Bernhard ; Windecker, Stephan

In: European Heart Journal, 2008, vol. 29, no. 6, p. 718-725

Cost-effectiveness of drug-eluting stents in elderly patients with coronary artery disease: the SENIOR trial

Bulsei, Julie ; Butel, Thibault ; Varenne, Olivier ; Cook, Stéphane ; Cuisset, Thomas ; Carrié, Didier ; Hovasse, Thomas ; Morice, Marie-Claude ; Sinnaeve, Peter R. ; Durand-Zaleski, Isabelle

In: Value in Health, 2019, vol. 22, no. 12, p. 1355–1361

Elderly patients receive bare metal stents instead of drug-eluting stents (DES) to shorten the duration of dual antiplatelet therapy (DAPT). The SENIOR trial compared outcomes between these 2 types of stents combined with a short duration of DAPT. A significant decrease in the number of patients with at least 1 major adverse cardiac and cerebrovascular event (MACCE) was noted in the DES...

Absorb bioresorbable scaffold versus xience metallic stent for prevention of restenosis following percutaneous coronary intervention in patients at high risk of restenosis: rationale and design of the COMPARE ABSORB trial

Chang, Chun Chin ; Onuma, Yoshinobu ; Achenbach, Stephan ; Barbato, Emanuele ; Chevalier, Bernard ; Cook, Stéphane ; Dudek, Dariusz ; Escaned, Javier ; Gori, Tommaso ; Kočka, Viktor ; Tarantini, Giuseppe ; E.J.West, Nick ; Morice, Marie-Claude ; G.P.Tijssen, Jan ; Geuns, Robert-Janvan ; C.Smits, Pieter

In: Cardiovascular Revascularization Medicine, 2019, vol. 20, no. 7, p. 577–582

Background: The advent of bioresorbable vascular scaffolds (BVS) was considered as a potential improvement in percutaneous coronary intervention (PCI) after the groundbreaking development of drug eluting stents (DES). However, the clinical performance, long-term safety and efficacy of BVS in complex coronary lesions remain uncertain. COMPARE ABSORB, a multicenter, single blind, prospective ...

Late thrombotic events after bioresorbable scaffold implantation: a systematic review and meta-analysis of randomized clinical trials

Collet, Carlos ; Asano, Taku ; Miyazaki, Yosuke ; Tenekecioglu, Erhan ; Katagiri, Yuki ; Sotomi, Yohei ; Cavalcante, Rafael ; Winter, Robbert J. de ; Kimura, Takeshi ; Gao, Runlin ; Puricel, Serban ; Cook, Stéphane ; Capodanno, Davide ; Onuma, Yoshinobu ; Serruys, PatrickW.

In: European Heart Journal, 2017, p. -

To compare the long-term safety and efficacy of bioresorbable vascular scaffold (BVS) with everolimus-eluting stent (EES) after percutaneous coronary interventions.Methods and Results: A systematic review and meta-analysis of randomized clinical trials comparing clinical outcomes of patients treated with BVS and EES with at least 24 months follow-up was performed. Adjusted random-effect model...

Heart rate never lies: interventional cardiologist and Braude’s quote revised

Cook, Stéphane ; Stauffer, Jean-Christophe ; Goy, Jean-Jacques ; Graf, Denis ; Puricel, Serban ; Frobert, Aurélien ; Muller, Olivier ; Togni, Mario ; Arroyo, Diego

In: Open Heart, 2016, vol. 3, no. 1, p. e000373

Background Interventional cardiologists may be immune to stress, allowing them to perform complex percutaneous interventions under pressure.Objectives To assess heart rate (HR) variations as a surrogate marker of stress of interventional cardiologists during percutaneous cardiac procedures and in every-day life.Design This is a single-centre...

Long-term outcomes after drug-eluting stent implantation: get your feet wet in the real-world

Cook, Stéphane ; Togni, Mario

In: Journal of Interventional Cardiology, 2010, vol. 23, no. 2, p. 176-178

Heart rate, coronary artery disease and plaque rupture – myth, hype, or truth?

Cook, Stéphane

In: Swiss Medical Weekly, 2012, vol. 142, p. w13661